Logo image of GENX.PA

GENERIX GROUP (GENX.PA) Stock Fundamental Analysis

EPA:GENX - Euronext Paris - Matif - FR0010501692 - Common Stock - Currency: EUR

9.7  +0.04 (+0.41%)

Fundamental Rating

2

Taking everything into account, GENX scores 2 out of 10 in our fundamental rating. GENX was compared to 101 industry peers in the Software industry. GENX has a bad profitability rating. Also its financial health evaluation is rather negative. GENX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

GENX had positive earnings in the past year.
Each year in the past 5 years GENX has been profitable.
Each year in the past 5 years GENX had a positive operating cash flow.
GENX.PA Yearly Net Income VS EBIT VS OCF VS FCFGENX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 2.84%
ROE 7.39%
ROIC 7.99%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GENX.PA Yearly ROA, ROE, ROICGENX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 2 4 6 8 10

1.3 Margins

Industry RankSector Rank
OM 7.39%
PM (TTM) 4.04%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GENX.PA Yearly Profit, Operating, Gross MarginsGENX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 40 60 80

More info and screens

2

2. Health

2.1 Basic Checks

GENX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
GENX has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, GENX has an improved debt to assets ratio.
GENX.PA Yearly Shares OutstandingGENX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
GENX.PA Yearly Total Debt VS Total AssetsGENX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

GENX has an Altman-Z score of 2.75. This is not the best score and indicates that GENX is in the grey zone with still only limited risk for bankruptcy at the moment.
GENX has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 2.75
ROIC/WACC1.18
WACC6.77%
GENX.PA Yearly LT Debt VS Equity VS FCFGENX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M 20M 30M 40M

2.3 Liquidity

GENX has a Current Ratio of 0.98. This is a bad value and indicates that GENX is not financially healthy enough and could expect problems in meeting its short term obligations.
GENX has a Quick Ratio of 0.98. This is a bad value and indicates that GENX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
GENX.PA Yearly Current Assets VS Current LiabilitesGENX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for GENX have decreased strongly by -33.12% in the last year.
GENX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.98% yearly.
Looking at the last year, GENX shows a small growth in Revenue. The Revenue has grown by 5.29% in the last year.
Measured over the past years, GENX shows a small growth in Revenue. The Revenue has been growing by 6.05% on average per year.
EPS 1Y (TTM)-33.12%
EPS 3Y11.67%
EPS 5Y42.98%
EPS Q2Q%-78.02%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y3.31%
Revenue growth 5Y6.05%
Sales Q2Q%2.07%

3.2 Future

Based on estimates for the next years, GENX will show a decrease in Earnings Per Share. The EPS will decrease by -3.42% on average per year.
The Revenue is expected to grow by 5.01% on average over the next years.
EPS Next Y-28.57%
EPS Next 2Y-4.88%
EPS Next 3Y-4.22%
EPS Next 5Y-3.42%
Revenue Next Year4.41%
Revenue Next 2Y5.53%
Revenue Next 3Y4.84%
Revenue Next 5Y5.01%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GENX.PA Yearly Revenue VS EstimatesGENX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
GENX.PA Yearly EPS VS EstimatesGENX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 80.83, which means the current valuation is very expensive for GENX.
The average S&P500 Price/Earnings ratio is at 26.19. GENX is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 63.40, the valuation of GENX can be described as expensive.
When comparing the Price/Forward Earnings ratio of GENX to the average of the S&P500 Index (22.13), we can say GENX is valued expensively.
Industry RankSector Rank
PE 80.83
Fwd PE 63.4
GENX.PA Price Earnings VS Forward Price EarningsGENX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.42
GENX.PA Per share dataGENX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as GENX's earnings are expected to decrease with -4.22% in the coming years.
PEG (NY)N/A
PEG (5Y)1.88
EPS Next 2Y-4.88%
EPS Next 3Y-4.22%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GENX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENERIX GROUP

EPA:GENX (8/23/2022, 7:00:00 PM)

9.7

+0.04 (+0.41%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap220.19M
Analysts85.71
Price Target9.69 (-0.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 80.83
Fwd PE 63.4
P/S 2.61
P/FCF N/A
P/OCF N/A
P/B 4.77
P/tB N/A
EV/EBITDA 20.42
EPS(TTM)0.12
EY1.24%
EPS(NY)0.15
Fwd EY1.58%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.72
BVpS2.03
TBVpSN/A
PEG (NY)N/A
PEG (5Y)1.88
Profitability
Industry RankSector Rank
ROA 2.84%
ROE 7.39%
ROCE N/A
ROIC 7.99%
ROICexc N/A
ROICexgc 40.65%
OM 7.39%
PM (TTM) 4.04%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 2.75
F-Score7
WACC6.77%
ROIC/WACC1.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.12%
EPS 3Y11.67%
EPS 5Y42.98%
EPS Q2Q%-78.02%
EPS Next Y-28.57%
EPS Next 2Y-4.88%
EPS Next 3Y-4.22%
EPS Next 5Y-3.42%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y3.31%
Revenue growth 5Y6.05%
Sales Q2Q%2.07%
Revenue Next Year4.41%
Revenue Next 2Y5.53%
Revenue Next 3Y4.84%
Revenue Next 5Y5.01%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A